McBride A - Search Results

1

National survey on the effect of oncology drug shortages on cancer care.

McBride A, Holle LM, Westendorf C, Sidebottom M, Griffith N, Muller RJ, Hoffman JM. McBride A, et al. Am J Health Syst Pharm. 2013 Apr 1;70(7):609-17. doi: 10.2146/ajhp120563. Am J Health Syst Pharm. 2013. PMID: 23515514

2

Formulary Selection Criteria for Biosimilars: Considerations for US Health-System Pharmacists.

Griffith N, McBride A, Stevenson JG, Green L. Griffith N, et al. Among authors: mcbride a. Hosp Pharm. 2014 Oct;49(9):813-25. doi: 10.1310/hpj4909-813. Hosp Pharm. 2014. PMID: 25477613 Free PMC article.

3

Eribulin mesylate: a novel halichondrin B analogue for the treatment of metastatic breast cancer.

McBride A, Butler SK. McBride A, et al. Am J Health Syst Pharm. 2012 May 1;69(9):745-55. doi: 10.2146/ajhp110237. Am J Health Syst Pharm. 2012. PMID: 22517020 Review.

4

National Survey on the Effect of Oncology Drug Shortages in Clinical Practice: A Hematology Oncology Pharmacy Association Survey.

McBride A, Hudson-DiSalle S, Pilz J, Hamm M, Boring B, Buie LW, DeRemer DL. McBride A, et al. JCO Oncol Pract. 2022 Aug;18(8):e1289-e1296. doi: 10.1200/OP.21.00883. Epub 2022 May 11. JCO Oncol Pract. 2022. PMID: 35544740

5

ASHP-HOPA guidelines on the roles and responsibilities of the pharmacy technician in ambulatory oncology pharmacy.

Bergsbaken J, Roman D, Earl MA, McBride A, Olin JL, Peele A, Reichard JS. Bergsbaken J, et al. Among authors: mcbride a. Am J Health Syst Pharm. 2018 Sep 1;75(17):1304-1311. doi: 10.2146/ajhp180270. Epub 2018 Jul 13. Am J Health Syst Pharm. 2018. PMID: 30006435 No abstract available.

6

Ibrutinib for treatment of chronic lymphocytic leukemia.

Vela CM, McBride A, Jaglowski SM, Andritsos LA. Vela CM, et al. Among authors: mcbride a. Am J Health Syst Pharm. 2016 Mar 15;73(6):367-75. doi: 10.2146/ajhp140760. Am J Health Syst Pharm. 2016. PMID: 26953281 Review.

7

Drug shortages in oncology.

McBride A, Johnson PE. McBride A, et al. Am J Health Syst Pharm. 2012 Jul 15;69(14):1190. doi: 10.2146/ajhp120136. Am J Health Syst Pharm. 2012. PMID: 22761069 No abstract available.

8

Implementation of a pharmacy-managed program for the transition of chemotherapy to the outpatient setting.

McBride A, Campen CJ, Camamo J, Maloney M, Persky D, Kurtin SE, Barket NL, Krishnadasan R, Elquza E, Anwer F, Weibel K. McBride A, et al. Am J Health Syst Pharm. 2018 May 1;75(9):e246-e258. doi: 10.2146/ajhp170138. Am J Health Syst Pharm. 2018. PMID: 29691269

9

Pharmacist perspectives and considerations for implementation of therapeutic oncology biosimilars in practice.

Cuellar S, McBride A, Medina P. Cuellar S, et al. Among authors: mcbride a. Am J Health Syst Pharm. 2019 Oct 15;76(21):1725-1738. doi: 10.1093/ajhp/zxz190. Am J Health Syst Pharm. 2019. PMID: 31612935 Review.

10

Carfilzomib: a second-generation proteasome inhibitor for the treatment of multiple myeloma.

McBride A, Klaus JO, Stockerl-Goldstein K. McBride A, et al. Am J Health Syst Pharm. 2015 Mar 1;72(5):353-60. doi: 10.2146/ajhp130281. Am J Health Syst Pharm. 2015. PMID: 25694410 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

771 results

Search Page

Filters